This seminar, from Sept. 29 – Oct. 1, 2010 at the PacificoYokohama, examined unique legal issues that arise during each phase of the pharmaceutical or medical device product life cycle in the United States. The event provided valuable information to corporate representatives currently considering or involved in bringing pharmaceutical goods to the U.S. market. Topics included an in-depth analysis of recent legal trends and developments related to R&D protocols, securing FDA and other regulatory agency approval, assessing risks of sales and marketing campaigns, as well as an industry outlook for 2011 and beyond. In addition to strategies to avoid both common and not so common problems that may occur, McGuireWoods lawyers Brian Parker, Melissa Gilmore, and Sidney Kanazawa offered insights into legal implications of non-compliance based on extensive, real life experiences with multi national pharmaceutical clients.
For more information, visit the BioJapan 2010 website.